Biomea Fusion (BMEA) Payables (2020 - 2026)
Biomea Fusion (BMEA) posted Payables of $4.6 million for Q1 2026, up 42.68% sequentially from $3.2 million in Q4 2025, and down 40.15% YoY from $7.7 million in Q1 2025.
Biomea Fusion (BMEA) Payables (2020 - 2026) Analysis & Trends
Biomea Fusion has reported Payables for 7 years, with the latest figure at $4.6 million in Q1 2026.
- Quarterly Payables fell 40.15% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (down 40.15% YoY) and the FY2025 annual result came in at $3.2 million, down 75.0% from the prior year.
- Payables improved to $4.6 million in Q1 2026 per BMEA's latest filing, from $3.2 million in the prior quarter.
- Over five years, Payables peaked at $12.9 million in Q4 2024 and troughed at $1.6 million in Q3 2022.
- A 5-year average of $5.6 million and a median of $5.3 million in 2023 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2025: Payables jumped 413.62% in 2022, then plunged 75.0% in 2025.
- Over 5 years, Payables stood at $6.8 million in 2022, then grew by 0.37% to $6.9 million in 2023, then jumped by 88.76% to $12.9 million in 2024, then slumped by 75.0% to $3.2 million in 2025, then jumped by 42.68% to $4.6 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $4.6 million, $3.2 million, and $6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Biomea Fusion | 97.69 Mn | 97.69 Mn | - | 3.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.31 Mn |
| Mar 31, 2026 | 4.61 Mn |
| Dec 31, 2025 | 3.23 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Jun 30, 2025 | 8.38 Mn |
| Mar 31, 2025 | 7.71 Mn |
| Dec 31, 2024 | 12.93 Mn |
| Sep 30, 2024 | 8.99 Mn |
| Jun 30, 2024 | 5.83 Mn |
| Mar 31, 2024 | 4.71 Mn |
| Dec 31, 2023 | 6.85 Mn |
| Sep 30, 2023 | 3.19 Mn |
| Jun 30, 2023 | 4.15 Mn |
| Mar 31, 2023 | 5.33 Mn |
| Dec 31, 2022 | 6.83 Mn |
| Sep 30, 2022 | 1.59 Mn |
| Jun 30, 2022 | 2.41 Mn |
| Mar 31, 2022 | 2.52 Mn |
| Dec 31, 2021 | 1.33 Mn |
| Sep 30, 2021 | 1.25 Mn |